Charles River Laboratories (CRL) Tops Q1 EPS by 8c; Boosts Outlook
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $181.27 -2.02%
EPS Growth %: -12.5%
Financial Fact:
Interest expense: -7.08M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -12.5%
Financial Fact:
Interest expense: -7.08M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.82, $0.08 better than the analyst estimate of $0.74. Revenue for the quarter came in at $299.4 million versus the consensus estimate of $302.08 million.
Charles River Laboratories sees FY2014 EPS of $3.15 - $3.25, versus prior guidance of $.00 - $3.10. Sees sales growth of 9 to 11 percent, from 3 to 5 percent prior.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- First BanCorp to Announce 2Q 2026 Results on July 22, 2026
- Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
